FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/CRL
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Charles River Laboratories Intl. Inc (CRL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Charles River Laboratories (CRL) trades at $359.69, down 4.36% today despite a bullish technical setup and strong analyst support. The stock shows positive earnings momentum with three consecutive quarterly beats, though fundamentals reveal challenges with negative net income margins and elevated valuation multiples. Recent investor day presentations highlighted a refreshed growth strategy targeting 5-7% revenue growth and $300 million in savings by 2030.
While technical indicators and analyst consensus (73% buy ratings) support upside potential, investors face significant fundamental risks including negative profitability, high debt levels, and premium valuations. The current price exceeds the consensus target of $308.36, suggesting near-term consolidation may precede sustained gains if margin improvement targets are achieved.
Read full analysis

Key Stats

  • Market Cap
    $16.16B
  • Volume
    1,620,562
  • Sector
    Health
  • 52W High
    $376.10
  • 52W Low
    $149.93
  • Typical Hold Time
    34 Days
  • Enterprise Value
    $19.00B
  • Div Yield
    -
  • Trading Activity
    -
$339
52W Low: $149.93
18 May 2026
52W High: $376.1
29 Oct 2026

Track Charles River Laboratories Intl. Inc (CRL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $149.93 and a high of $376.1, highlighting its annual price range. Buy and sell Charles River Laboratories Intl. Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Most Recent News

Content is generated by Aura AI

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
1 hour ago
Na
Bullish
news icon
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
1 hour ago
Na
Bullish
news icon
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Potato chips market to hit $84B by 2032, driven by flavor innovation and local manufacturing.

The global potato chips market is expected to grow from $59.67 billion in 2026 to $84.26 billion by 2032, at a CAGR of 5.88%. Growth is fueled by local manufacturing, individual packaging, and flavor innovation, which help brands meet diverse consume...

Market News
3 hours ago
Mordor Intelligence
Neutral
Potato chips market to hit $84B by 2032, driven by flavor innovation and local manufacturing.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $16.16B
  • Volume
    1,620,562
  • Sector
    Health
  • 52W High
    $376.10
  • 52W Low
    $149.93
  • Typical Hold Time
    34 Days
  • Enterprise Value
    $19.00B
  • Div Yield
    -
  • Trading Activity
    -
$339
52W Low: $149.93
18 May 2026
52W High: $376.1
29 Oct 2026

Track Charles River Laboratories Intl. Inc (CRL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $149.93 and a high of $376.1, highlighting its annual price range. Buy and sell Charles River Laboratories Intl. Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!